Cantitate/Preț
Produs
Total produse
Vezi coșul
Pulmonary Tuberculosis and Its Prevention de Takefumi Saito

Pulmonary Tuberculosis and Its Prevention: Respiratory Disease Series: Diagnostic Tools and Disease Managements

Editat de Takefumi Saito, Masahiro Narita, Charles L. Daley
en Limba Engleză Hardback – 21 oct 2022
Every year, 10 million people fall ill with tuberculosis (TB) in the world, and of those, 1.5 million people die even though it is a preventable and curable disease. As a result, TB remains the world’s leading infectious cause of death. On the other hand, in industrialized countries, the TB incidence has fallen to a historic low, and clinicians’ experience with TB diminished significantly in recent years. Additional challenges for clinicians include atypical presentation of TB in the immunocompromised, especially among the elderly, and an increasing number of patients with drug-resistant TB. Delayed diagnosis of TB leads to the spread of TB including nosocomial transmission because TB is an air-borne infectious disease, and suboptimal treatment can result in development of drug resistance.  Furthermore, treatment of latent TB infection (LTBI) can prevent future TB cases but it has been under-utilized despite recent innovations in diagnosis and treatment regimens of LTBI. This bookfocuses on advances in diagnostic tools and treatment for both TB disease and latent TB infection. Each chapter/topic is written by one of the top TB experts in the field and the authors are from Japan and the US.  

Pulmonary Tuberculosis and its Prevention offers up-to-date information that can be incorporated into a busy practice of clinicians while they can appreciate broad international perspectives and gain in-depth knowledge on TB.
Citește tot Restrânge

Din seria Respiratory Disease Series: Diagnostic Tools and Disease Managements

  • 5% Chronic Obstructive Pulmonary Disease: A Systemic Inflammatory Disease
    Preț: 127841 lei
  • 5% Drug-Induced Lung Injury
    Preț: 70748 lei
  • 5% Acute Respiratory Distress Syndrome: Advances in Diagnostic Tools and Disease Management
    Preț: 63832 lei
  • 5% Influenza: Advances in Diagnosis and Management
    Preț: 101521 lei
  • 5% Malignant Pleural Mesothelioma: Advances in Pathogenesis, Diagnosis, and Treatments
    Preț: 59395 lei
  • 5% Clinical Relevance of Genetic Factors in Pulmonary Diseases
    Preț: 66203 lei
  • 5% Disaster and Respiratory Diseases
    Preț: 65532 lei
  • 5% Advances in Asthma: Pathophysiology, Diagnosis and Treatment
    Preț: 44387 lei
  • 5% Aspiration Pneumonia: The Current Clinical Giant for Respiratory Physicians
    Preț: 70536 lei
  • 5% Structure-Function Relationships in Various Respiratory Systems: Connecting to the Next Generation
    Preț: 65864 lei

Preț: 71052 lei

Preț vechi: 74792 lei
-5% Nou

Puncte Express: 1066
Preț estimativ în valută:
13598€ • 14201$ • 11274£

Carte disponibilă

Livrare economică 21 ianuarie-04 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9789811939945
ISBN-10: 9811939942
Pagini: 294
Ilustrații: VIII, 294 p. 52 illus., 43 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.59 kg
Ediția:1st ed. 2022
Editura: Springer Nature Singapore
Colecția Springer
Seria Respiratory Disease Series: Diagnostic Tools and Disease Managements

Locul publicării:Singapore, Singapore

Cuprins

Part I. Epidemiology and Pathogenesis.- Chapter 1. Epidemiology.- Chapter 2. Immunology.- Chapter 3. Impact of Biologic and JAK Inhibitor Therapies on TB: How do Biologic Therapies Affect the Presentation and Treatment Course of Pulmonary TB?.- Chapter 4. Advances in Mycobacterial Laboratories: What is the latest laboratory approach to diagnose and manage pulmonary tuberculosis?.- Part IIPulmonary Tuberculosis.- Chapter 5. Advances in Diagnostics of Pulmonary tuberculosis: What is the Latest Approach to Diagnose Pulmonary TB?.- Chapter 6. HRCT diagnosis of pulmonary tuberculosis: Microlesions.- Chapter 7. Advances in Treatment of Drug Resistant Pulmonary TB: What is the latest approach to treat drug-resistant pulmonary TB?.- Chapter 8. The Role of Surgical Interventions for Pulmonary TB: What is the Role of Surgical Intervention in Pulmonary TB?.- Part III  Latent TB Infection: TB Prevention.- Chapter 9. Advances in Diagnosis of Latent TB Infection: What is the Latest Approach to Diagnose Latent TB Infection to Prevent TB?.- Chapter 10. Advances in Treatment of Latent TB Infection: What is the Latest Approach to Treat Latent TB Infection to Prevent Pulmonary TB?.- Part IV  Research Areas.- Chapter 11. TB vaccines: What Type of TB Vaccines are Studied and will be Available in the Future?.- Chapter 12. Clinical Trials of Pulmonary TB: Challenges and Opportunities.- Chapter 13. Contributions of Japanese Scholars to Advances in Clinical Tuberculosis Management: In TB World, What Kind of Achievements are Accomplished by Japanese Researchers?.

Notă biografică

Takefumi Saito, MD, PhD
National Hospital Organization Ibarakihigashi Hospital

Masahiro Narita, MD
University of Washington

Charles Daley, MD
National Jewish Health
University of Colorado

Textul de pe ultima copertă

Every year, 10 million people fall ill with tuberculosis (TB) in the world, and of those, 1.5 million people die even though it is a preventable and curable disease. As a result, TB remains the world’s leading infectious cause of death. On the other hand, in industrialized countries, the TB incidence has fallen to a historic low, and clinicians’ experience with TB diminished significantly in recent years. Additional challenges for clinicians include atypical presentation of TB in the immunocompromised, especially among the elderly, and an increasing number of patients with drug-resistant TB. Delayed diagnosis of TB leads to the spread of TB including nosocomial transmission because TB is an air-borne infectious disease, and suboptimal treatment can result in development of drug resistance.  Furthermore, treatment of latent TB infection (LTBI) can prevent future TB cases but it has been under-utilized despite recent innovations in diagnosis and treatment regimens of LTBI. This bookfocuses on advances in diagnostic tools and treatment for both TB disease and latent TB infection. Each chapter/topic is written by one of the top TB experts in the field and the authors are from Japan and the US.  

Pulmonary Tuberculosis and its Prevention offers up-to-date information that can be incorporated into a busy practice of clinicians while they can appreciate broad international perspectives and gain in-depth knowledge on TB.

Caracteristici

Offers up-to-date information that can be incorporated into a busy practice of clinicians Provides broad international perspectives and gain in-depth knowledge on TB Each chapter/topic is written by one of the top TB experts in the field and the authors are from Japan and the US